Clinical Efficacy of Reduced Glutathione in Combination with Polyene Phosphatidylcholine for Non-alcoholic Fatty Liver Disease / 中国药房

ABSTRACT

OBJECTIVE:To observe the clinical efficacy of reduced glutathione combined with Polyene Phosphatidylcholine for non-alcoholic fatty liver disease. METHODS: 60 patients with non-alcoholic fatty liver disease were randomly divided into trial group and control group: 30 patients in trial group were infused iv gtt with Polyene Phosphatidylcholine (10 mL) and reduced glutathione (1 200 mg) once daily for 1 months,and 30 in control group with Polyene Phosphatidylcholine (10 mL) once daily for 1 months. Parameters of liver function and blood lipid and color ultrasonic examination of two groups before and after treatment were compared for evaluation of therapeutic effects. RESULTS: In respect of the reduction of alanine aminotransferase (ALT),aspartate aminotransferase (AST) and ?-GT,there were significant differences between the trial group and the control group in the effective rate (90.0% in trial group versus 63.3 % in control group,P0.05). CONCLUSION: Used concomitantly,reduced glutathione and Polyene Phosphatidylcholine showed satisfactory efficacy for non-alcoholic fatty liver disease.